MX9305933A - Metodo para antagonizar al 1,4,5-trifosfato de inositol. - Google Patents
Metodo para antagonizar al 1,4,5-trifosfato de inositol.Info
- Publication number
- MX9305933A MX9305933A MX9305933A MX9305933A MX9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A
- Authority
- MX
- Mexico
- Prior art keywords
- inositol
- triphosphate
- antagonize
- oligometers
- formula
- Prior art date
Links
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 title abstract 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyurethanes Or Polyureas (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95239392A | 1992-09-28 | 1992-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9305933A true MX9305933A (es) | 1994-04-29 |
Family
ID=25492868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9305933A MX9305933A (es) | 1992-09-28 | 1993-09-27 | Metodo para antagonizar al 1,4,5-trifosfato de inositol. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0661982A1 (en:Method) |
| JP (1) | JPH08502068A (en:Method) |
| KR (1) | KR950703347A (en:Method) |
| AU (1) | AU670962B2 (en:Method) |
| CA (1) | CA2145681A1 (en:Method) |
| HU (1) | HUT70192A (en:Method) |
| IL (1) | IL107066A (en:Method) |
| MX (1) | MX9305933A (en:Method) |
| NO (1) | NO951163L (en:Method) |
| NZ (1) | NZ256178A (en:Method) |
| TW (1) | TW260663B (en:Method) |
| WO (1) | WO1994007507A1 (en:Method) |
| ZA (1) | ZA936978B (en:Method) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996000586A2 (en) * | 1994-06-30 | 1996-01-11 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for treating cell proliferative disorders by modulating signal transduction |
| US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| JPH11503110A (ja) | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体拮抗剤 |
| US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
| US6005008A (en) * | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
| US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| JP2000514049A (ja) * | 1996-06-27 | 2000-10-24 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ―８受容体拮抗薬 |
| TR199802695T2 (xx) | 1996-06-27 | 1999-04-21 | Smithkline Beecham Corporation | IL-8 Resept�r kar��tlar� |
| ATE358486T1 (de) * | 2000-11-09 | 2007-04-15 | Contrimmune Biotechnology Inc | Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion |
| WO2013033657A2 (en) | 2011-09-02 | 2013-03-07 | The Trustees Of Columbia University In The City Of New York | CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB781479A (en) * | 1953-08-27 | 1957-08-21 | Ciba Ltd | New polyureas and process for making them |
| US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
-
1993
- 1993-08-30 WO PCT/US1993/008168 patent/WO1994007507A1/en not_active Application Discontinuation
- 1993-08-30 AU AU48417/93A patent/AU670962B2/en not_active Ceased
- 1993-08-30 NZ NZ256178A patent/NZ256178A/en unknown
- 1993-08-30 JP JP6509054A patent/JPH08502068A/ja active Pending
- 1993-08-30 HU HU9500891A patent/HUT70192A/hu unknown
- 1993-08-30 KR KR1019950701166A patent/KR950703347A/ko not_active Ceased
- 1993-08-30 CA CA002145681A patent/CA2145681A1/en not_active Abandoned
- 1993-08-30 EP EP93921252A patent/EP0661982A1/en not_active Ceased
- 1993-09-21 ZA ZA936978A patent/ZA936978B/xx unknown
- 1993-09-22 IL IL107066A patent/IL107066A/en not_active IP Right Cessation
- 1993-09-22 TW TW082107787A patent/TW260663B/zh active
- 1993-09-27 MX MX9305933A patent/MX9305933A/es unknown
-
1995
- 1995-03-27 NO NO951163A patent/NO951163L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW260663B (en:Method) | 1995-10-21 |
| IL107066A (en) | 1998-01-04 |
| ZA936978B (en) | 1994-04-18 |
| WO1994007507A1 (en) | 1994-04-14 |
| JPH08502068A (ja) | 1996-03-05 |
| HUT70192A (en) | 1995-09-28 |
| NO951163D0 (no) | 1995-03-27 |
| IL107066A0 (en) | 1993-12-28 |
| KR950703347A (ko) | 1995-09-20 |
| HU9500891D0 (en) | 1995-05-29 |
| AU670962B2 (en) | 1996-08-08 |
| NZ256178A (en) | 1997-03-24 |
| NO951163L (no) | 1995-03-27 |
| AU4841793A (en) | 1994-04-26 |
| EP0661982A1 (en) | 1995-07-12 |
| CA2145681A1 (en) | 1994-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69324859D1 (de) | Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis | |
| MX9305933A (es) | Metodo para antagonizar al 1,4,5-trifosfato de inositol. | |
| CU23393A3 (es) | Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen | |
| BR0116001A (pt) | Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda | |
| ES2108120T3 (es) | Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf. | |
| ES2135083T3 (es) | Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis. | |
| ES2120993T3 (es) | Agentes antitromboticos. | |
| DE69022953D1 (de) | Zusammensetzungen zur Behandlung von Fettablagerungen. | |
| ES2116436T3 (es) | Carbamatos y agentes protectores de las plantas que les contienen. | |
| PT729468E (pt) | Antagonistas nao peptidicos de receptores de taquiquininas | |
| ES2070981T3 (es) | Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo. | |
| GB9514451D0 (en) | Sustained-release formulation | |
| MX9207494A (es) | 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| ES2058346T3 (es) | Compuestos piperidinilicos 1,4-disustituidos. | |
| GB2223169B (en) | Inositol trisphosphate for the treatment of bone disorders | |
| ES2011427T3 (es) | Derivados de la oxima de octahidronaftaleno para la inhibicion de la sintesis del colesterol, procedimientos para su preparacion y composiciones que los contienen. | |
| ES2060239T3 (es) | Analogos de bis(alquil-sustituido-4-hidroxifeniltio)alcano como inhibidores de la formacion de cataratas. | |
| MX9301298A (es) | Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
| ATE232387T1 (de) | Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes | |
| SE9404568D0 (sv) | The use of inositoltrisphosphate for the preparing of medicaments | |
| MX9305914A (es) | 2-arilpirroles, procedimiento para su preparacion y agentes pesticidas quelos contienen. | |
| MX166685B (es) | Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas | |
| DE69424747D1 (de) | Pharmazeutische Zusammensetzung zur Vorbeugung oder Behandlung von Knochenbrüchen |